1. Van Erven L, Schalij MJ. Amiodarone: an effective antiarrhythmicdrug with unusual side effects. Heart. 2010;96(19):1593-1600.doi:10.1136/hrt.2008.152652
2. Eskes SA, Wiersinga WM. Amiodarone and thyroid. Best Pract Res ClinEndocrinol Metab. 2009;23(6):735-751. doi:10.1016/j.beem.2009.07.001
3. Amador F, Mendonça F, da Costa C, et al. Total thyroidectomyin a patient awaiting heart transplant with amiodarone-inducedthyrotoxicosis: a case report. Clin Case Rep. 2023;11(2):e6892.doi:10.1002/ccr3.6892
4. Narayana SK, Woods DR, Boos CJ. Management of amiodarone-relatedthyroid problems. Ther Adv Endocrinol Metab. 2011;2(3):115-126.doi:10.1177/2042018811398516
5. Medic F, Bakula M, Alfirevic M, Bakula M, Mucic K, Maric N.Amiodarone and thyroid dysfunction. Acta Clin Croat. 2022;61(2):327-341. doi:10.20471/acc.2022.61.02.20
6. Florek JB, Lucas A, Girzadas D. Amiodarone. In: StatPearls. TreasureIsland (FL): StatPearls Publishing; 2023.
7. Eng PH, Cardona GR, Fang SL, et al. Escape from the acute Wolff-Chaikoff effect is associated with a decrease in thyroid sodium/iodidesymporter messenger ribonucleic acid and protein. Endocrinology.1999;140(8):3404-3410.
8. Ursella S, Testa A, Mazzone M, Gentiloni Silveri N. Amiodarone-induced thyroid dysfunction in clinical practice. Eur Rev MedPharmacol Sci. 2006;10(5):269-278.
9. Basaria S, Cooper DS. Amiodarone and the thyroid. Am J Med.2005;118(7):706-714. doi:10.1016/j.amjmed.2004.11.028
10. Trohman RG, Sharma PS, McAninch EA, Bianco AC. Amiodarone andthyroid physiology, pathophysiology, diagnosis and management. TrendsCardiovasc Med. 2019;29(5):285-295. doi:10.1016/j.tcm.2018.09.005
11. Trip MD, Wiersinga W, Plomp TA. Incidence, predictability,and pathogenesis of amiodarone-induced thyrotoxicosis andhypothyroidism. Am J Med. 1991;91(5):507-511.
12. Martino E, Aghini-Lombardi F, Mariotti S, et al. Amiodarone iodine-induced hypothyroidism: risk factors and follow-up in 28 cases. ClinEndocrinol. 1987;26(2):227-237.